Liposomal doxorubicin increases radiofrequency ablation-induced tumor destruction by increasing cellular oxidative

Stephanie A Solazzo1, Muneeb Ahmed, Rachel Schor-Bardach

  • 1Laboratory for Minimally Invasive Tumor Therapies, Department of Radiology, Beth Israel Deaconess Medical Center, Harvard Medical School, 330 Brookline Ave, Boston, MA 02215, USA.

Radiology
|February 18, 2010
PubMed
Abstract